OpenAI is rapidly advancing its deep learning systems, aiming to develop an intern-level AI research assistant by September 2026 and a fully autonomous AI researcher by 2028, according to CEO Sam Altman. This announcement coincides with OpenAI’s transition to a public benefit corporation, allowing greater flexibility for capital raising while committing to responsible AI development. Chief Scientist Jakub Pachocki underscored the goal of achieving superintelligence within a decade, enabling AI to outperform humans in critical tasks. OpenAI plans to enhance algorithmic innovation and significantly increase “test time compute,” dedicating substantial computational resources to complex problems, which could lead to major scientific breakthroughs. This shift also involves a $25 billion commitment to use AI for curing diseases. The for-profit branch will support infrastructure scaling, necessitating a $1.4 trillion investment in the coming years to foster advancements across various fields like medicine and technology.
Source link
